Showing results (271-280 of 584) with videos related to
Sort By:
Pageof 59
Journal of Gastroenterology|June 26, 2016
Differences in the risk of fatty liver for onset of impaired fasting glucose according to baseline plasma glucose levelsTeruki Miyake, Masashi Hirooka, Osamu Yoshida, et al.Gastro Hep Advances|June 8, 2026
The Cardiovascular Risk Paradox in Normal-Weight Steatotic Liver Disease Beyond Body Mass Index-Based DetectionMasashi Hirooka, Teruki Miyake, Ryo Yano, et al.Internal Medicine (Tokyo, Japan)|August 23, 2023
Renal Cell Carcinoma and Hepatocellular Carcinoma in a Patient with Wilson's DiseaseShogo Kitahata, Kojiro Michitaka, Miyuki Kinebuchi, et al.Hepatology Research : the Official Journal of the Japan Society of Hepatology|January 29, 2011
Simple formula to predict response to peginterferon alpha2b and ribavirin combination therapy in genotype 1 chronic hepatitis C patients with high viral loadsYoshito Itoh, Takeshi Nishimura, Hiroaki Hashimoto, et al.Journal of Gastroenterology|March 14, 2016
Low alcohol consumption increases the risk of impaired glucose tolerance in patients with non-alcoholic fatty liver diseaseTeruki Miyake, Teru Kumagi, Masashi Hirooka, et al.Gastro Hep Advances|March 9, 2026
Competing Cardiometabolic Pathways of Obesity and Metabolic Dysfunction-associated Steatotic Liver DiseaseMasashi Hirooka, Teruki Miyake, Ryo Yano, et al.World Journal of Hepatology|December 9, 2015
Alpha-fetoprotein and des-gamma-carboxy-prothrombin at twenty-four weeks after interferon-based therapy predict hepatocellular carcinoma developmentSatoshi Shakado, Shotaro Sakisaka, Kazuaki Chayama, et al.Journal of Gastroenterology|November 21, 2020
The transition in the etiologies of hepatocellular carcinoma-complicated liver cirrhosis in a nationwide survey of JapanHirayuki Enomoto, Yoshiyuki Ueno, Yoichi Hiasa, et al.Biochemical and Biophysical Research Communications|October 5, 2019
Intranasal vaccination with HBs and HBc protein combined with carboxyl vinyl polymer induces strong neutralizing antibody, anti-HBs IgA, and IFNG responseTakahiro Sanada, Naoki Yamamoto, Mohammad Enamul Hoque Kayesh, et al.Journal of Medical Virology|May 7, 2020
Sex difference in the development of hepatocellular carcinoma after direct-acting antiviral therapy in patients with HCV infectionTakao Watanabe, Yoshio Tokumoto, Kouji Joko, et al.Pageof 59